LONDON (ShareCast) - (Sharecast News) - ECO Animal Health has entered a worldwide exclusive development and licencing deal with Ghent University-PROVAXS, it announced on Wednesday.
The AIM-traded firm said the deal would allow it to further develop, register and commercialise a Clostridium perfringens vaccine for poultry, based on antigens co-developed by Professor Filip Van Immerseel of Ghent University and Professor Rick Titball of the University of Exeter.

Clostridium perfringens is a bacterium which normally inhabits the gastrointestinal system, but when predisposing triggers are present, specific strains can cause necrotic enteritis with major consequences for bird health and growth, ECO explained.

"We are delighted to have entered into this collaboration with Ghent University," said ECO Animal Health Group non-executive chairman Peter Lawrence.

"Necrotic enteritis can result in a significant reduction in body weight and increase in feed conversion rate when compared with healthy broilers."

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE